KRAS transitions and villous growth in colorectal adenomas [3]

Cellular Oncology

Volumn 27, Issue 5-6, 2005, Pages 363-366

  Risio, Mauro ^a   Malacarne, Davide ^b   Giaretti, Walter ^b  

^a CANDIOLO CANCER INSTITUTE   (Italy)

^b UNIVERSITY OF GENOA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

AMINO ACID; APC PROTEIN; BETA CATENIN; PROTEIN P53; SMAD4 PROTEIN;

AMINO ACID SUBSTITUTION; CANCER RISK; COLON POLYPOSIS; COLORECTAL ADENOMA; DISEASE SEVERITY; FLUORESCENCE ACTIVATED CELL SORTING; HUMAN; INTESTINE VILLUS; LETTER; PATHOPHYSIOLOGY; PRIORITY JOURNAL; SOMATIC MUTATION; TUMOR GROWTH; TUMOR LOCALIZATION; TUMOR VOLUME; WORLD HEALTH ORGANIZATION;

ADENOMA; ADENOMA, VILLOUS; ADULT; AGED; AGED, 80 AND OVER; COLORECTAL NEOPLASMS; DATA INTERPRETATION, STATISTICAL; DISEASE PROGRESSION; FEMALE; FLOW CYTOMETRY; GENE EXPRESSION REGULATION, NEOPLASTIC; GENES, RAS; HUMANS; MALE; MIDDLE AGED; MUTATION; SEQUENCE ANALYSIS, DNA;

EID: 29244470865     PISSN: 15705870     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Letter

References (41)

1. F. Al-Mulla and E.M. MacKenzie, Differences in in vitro invasive capacity induced by differences in Ki-Ras protein mutations, J. Pathol. 195 (2001), 549-556.
2. F. Al-Mulla, E.J. Milner-White, J.J. Going and G.D. Birnie, Structural differences between valine-12 and aspartate-12 Ras proteins may modify carcinoma aggression, J. Pathol. 187 (1999), 433-438.
3. H.J. Andreyev, A.R. Norman, D. Cunningham, J. Oates, B.R. Dix, B.J. Iacopetta et al., Kirsten ras mutations in patients with colorectal cancer: the 'RASCAL II' study, Br. J. Cancer 85 (2001), 692-696.
4. G. Auer, U. Kronenwett, U. Roblick, B. Franzén, J. Habermann, R. Sennerstam and T. Ried, Human breast adenocarcinoma: DNA content, chromosomes, gene expression and prognosis, Cell. Oncol. 26 (2004), 171-174.
5. P. Castagnola, W. Giaretti, Mutant KRAS, chromosomal instability and prognosis in colorectal cancer, BBA-Rev. Cancer (2005) [Epub ahead of print].
6. L. De Benedetti, S. Sciallero, V. Gismondi, R. James, A. Bafico, R. Biticchi et al., Association of APC gene mutations and histological characteristics of colorectal adenomas, Cancer Res. 54 (1994), 3553-3556.
7. S. Derks, M.H. Lentjes, D.M. Hellebrekers, A.P. de Bruine, J.G. Herman, M. van Engeland, Methylation-specific PCR unraveled, Cell. Oncol. 26 (2004) 291-299.
8. E.J. Douglas, H. Fiegler, A. Rowan, S. Halford, D.C. Bicknell, W. Bodmer et al., Array comparative genomic hybridization analysis of colorectal cancer cell lines and primary carcinomas, Cancer Res. 64 (2004), 4817-1825.
9. P. Duesberg, R. Li, D. Rasnick, A. Fabarius and R. Hehlmann, Carcinogenesis by aneuploidization, Cell. Oncol. 26 (2004), 181-186.
10. E.R. Fearon and B. Vogelstein. A genetic model for colorectal tumorigenesis, Cell 61 (1990), 759-767.
11. E. Geido, A. Sciutto, A. Rubagotti, C. Oliani, R. Monaco, M. Risio and W. Giaretti, Combined DNA flow cytometry and sorting with k-ras2 mutation spectrum analysis and the prognosis of human sporadic colorectal cancer, Cytometry 50 (2002), 216-224.
12. W. Giaretti, N. Pujic, A. Rapallo, S. Nigro, A. Di Vinci, E. Geido and M. Risio, K-ras-2 G-C and G-T transversions correlate with DNA aneuploidy in colorectal adenomas, Gastroenterology 108 (1995), 1040-1047.
13. W. Giaretti, A. Rapallo, E. Geido, A. Sciutto, F. Merlo, M. Risio and F.P. Rossini, Specific K-ras2 mutations in human sporadic colorectal adenomas are associated with DNA near-diploid aneuploidy and inhibiytion of proliferation, Am. J. Path. 153 (1998), 1201-1209.
14. W. Giaretti, S. Molinu, J. Ceccarelli and C. Prevosto, Chromosomal instability, aneuploidy, and gene mutations in human sporadic colorectal adenomas, Cell. Oncol. 26 (2004), 301-305.
15. W. Giaretti and D. Malacarne, Chromosomal instability, aneuploidy, and gene mutations in human sporadic colorectal adenomas, Cell. Oncol. 27 (2005), 269-271.
16. M. Hermsen, C. Postma, J. Baak, M. Weiss, A. Rapallo, A. Sciutto et al., Colorectal adenoma to carcinoma progression follows multiple pathways of chromosomal instability, Gastroenterology 123 (2002), 1109-1119.
17. K.P. Janssen, M. Abala, F. El Marjou, D. Louvard, S. Robine, Mouse models of K-ras-initiated carcinogenesis, BBA-Rev. Cancer (2005) [Epub ahead of print].
18. J.R. Jass and L.H. Sobin, Histological Typing of intestinal Tumours, WHO International Histological Classification of Tumours, Springer-Verlag, 1989.
19. J.F. Kerr, C.M. Winteford and B.V. Harmon, Apoptosis: its significance in cancer and therapy, Cancer 73 (1994), 2013-2026.
20. K.W. Kinzler and B. Vogelstein, Lessons from hereditary colorectal cancer, Cell 87 (1996), 159-170.
21. C. Lengauer, K.W. Kinzler and B. Vogelstein, Genetic instabilities in human cancers, Nature 396 (1998), 643-649.
22. R. Monaco, J.M. Chen, D. Chung, P. Brandt-Rauf and M.R. Pincus, Comparison of the computed three-dimensional structures of oncogenic forms (bound to GDP) of the ras-gene-encoded p21 protein with the structure of the normal (non-transforming) wild-type protein, J. Protein. Chem. 14 (1995), 457-466.
23. T. Muto, H. J.R. Bussey and B.C. Morson, The evolution of cancer of the rectum, Cancer 36 (1975), 2251-2270.
24. I. Petersen, Chromosome, ploidy and genetic imbalances of lung cancer, Cell. Oncol. 26 (2004), 173-174.
25. T.P. Pretlow and T.G. Pretlow, Mutant KRAS in aberrant crypt foci (ACF): Initiation of colorectal cancer?, BBA-Rev. Cancer (2005) [Epub ahead of print].
26. P.S. Rabinovitch, Genomic instability and progression to cancer in two models of preneoplastic disease: Barrett's esophagus and ulcerative colitis, Cell. Oncol. 26 (2004), 210-211.
27. H. Rajagopalan, M.A. Nowak, B. Vogelstein and C. Lengauer, The significance of unstable chromosomes in colorectal cancer, Nat. Rev. Cancer 3 (2003), 695-701.
28. D. Rasnick, Aneuploidy theory provides the "alternative plausible" explanation of cancer, Cell. Oncol. 26 (2004), 194-198.
29. T. Ried, M.J. Difilippantonio, C. Montagna, K. Heselmeyer-Haddad, H. Padilla-Nash, J. Habermann and M. Upender, Patterns and consequences of chromosomal aneuploidy in cancer cells, Cell. Oncol. 26 (2004), 224-225.
30. R.A. Risques, V. Moreno, M. Ribas, E. Marcuello, G. Capellà and M.A. Peinado, Genetic pathways and determinants of clinical outcome in colorectal cancer, Cell. Oncol. 26 (2004), 207-209.
31. C.A. Rubio, T. Alm, A. Aly and B. Poppen, Intraepithelial bodies in colorectal adenomas: Leuchtenberger bodies revisited, Dis. Colon Rectum 34 (1991), 47-50.
32. J. Sambrook, E.F. Fritsch and T. Maniatis, Molecular Cloning, Cold Spring Harbor Laboratory Press, Cold Spring Harbor, NY, 1989.
33. E. Saraga, D. Bautista, G. Dorta, P. Chaubert, P. Martin, B. Sordat et al., Genetic heterogeneity in sporadic colorectal adenomas, J. Pathol. 18 (1997), 281-286.
34. N. Smakman, I.H. Borel Rinkes, E.E. Voest and O. Kranenburg, Control of colorectal metastasis formation by K-Ras, BBA-Rev. Cancer (2005) [Epub ahead of print].
35. R.G. Steinbeck, Pathologic telophases: significant source of interphase aneuploidy, Cell. Oncol. 26 (2004), 233-236.
36. J. Sudbo and A. Reith, The evolution of predictive oncology and molecular-based therapy for oral cancer prevention, Int. J. Cancer 115 (2005), 339-345.
37. J. Sudbo, S.M. Lippman, J.J. Lee, L. Mao, W. Kildal, A. Sudbo et al., DNA content as a prognostic marker in patients with oral leukoplakia, N. Engl. J. Med. 344 (2001), 1270-1278.
38. M.B. Terry, A.I. Neugat, R.M. Bostick, J.D. Potter, R.W. Haile and C.M. Fenoglio-Preiser, Reliability in the classification of advanced colorectal adenomas, Cancer Epidemiol. Biomarkers Prev. 11 (2000), 660-663.
39. E. Torlakovic, E. Skovlund, D.C. Snover, G. Torlakovic and J.M. Nesland, Morphologic reappraisal of serrated colorectal polyps, Am. J. Surg. Pathol. 27 (2003), 65-81.
40. S.J. Winawer, A.G. Zauber, M.N. Ho, M.J. O'Brien, L.S. Gottlieb, S.S. Sternberg et al., Prevention of colorectal cancer by colonoscopic polipectomy. The National Polyp Study Work-group, N. Engl. J. Med. 329 (1993), 1977-1981.
41. Yuen, H. Davies, T.L. Chan, J.W. Ho, G.R. Bignell, C. Cox et al., Similarity of the phenotypic patterns asoociated with BRAF and KRAS mutations in colorectal neoplasia, Cancer Res. 62 (2002), 6451-6455.